Abbott Laboratories SEC filings ABT

Abbott Laboratories has 1,001 filings in SEC EDGAR's recent list, going back to Jul 12, 2018. Its latest annual report, Form ARS, was filed on Mar 13, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 21, 2026 (other events). The company's fiscal year ends on December 31.

Abbott Laboratories SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
8-K Current report
Other events
Oct 21, 2026 Oct 21, 2026
8-K Current report
Results of operations
Oct 21, 2026 Oct 21, 2026
4 Insider transaction Oct 2, 2026 Sep 30, 2026
4 Insider transaction Oct 2, 2026 Sep 30, 2026
4 Insider transaction Oct 2, 2026 Sep 30, 2026
4 Insider transaction Oct 2, 2026 Sep 30, 2026
4 Insider transaction Oct 2, 2026 Sep 30, 2026
4 Insider transaction Sep 25, 2026 Sep 23, 2026
4 Insider transaction Sep 3, 2026 Sep 1, 2026
4 Insider transaction Sep 3, 2026 Sep 1, 2026
144 Notice of proposed sale Sep 2, 2026 —
4 Insider transaction Aug 27, 2026 Aug 25, 2026
144 Notice of proposed sale Aug 25, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Aug 20, 2026 Aug 20, 2026
4 Insider transaction Aug 13, 2026 Aug 11, 2026
144 Notice of proposed sale Aug 11, 2026 —
10-Q Quarterly report Jul 28, 2026 Jun 30, 2026
8-K Current report
Results of operations
Jul 16, 2026 Jul 16, 2026
4 Insider transaction Jul 1, 2026 Jun 30, 2026
4 Insider transaction Jul 1, 2026 Jun 30, 2026
4 Insider transaction Jul 1, 2026 Jun 30, 2026
4 Insider transaction Jul 1, 2026 Jun 30, 2026
4 Insider transaction Jul 1, 2026 Jun 30, 2026
4 Insider transaction Jul 1, 2026 Jun 30, 2026
4 Insider transaction Jun 29, 2026 Jun 27, 2026
4 Insider transaction Jun 18, 2026 May 7, 2026
11-K Employee savings plan report Jun 18, 2026 Dec 31, 2025
SD Specialized disclosure (conflict minerals) May 27, 2026 —
144 Notice of proposed sale May 15, 2026 —
4 Insider transaction Apr 29, 2026 Apr 28, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 29, 2026 —
10-Q Quarterly report Apr 29, 2026 Mar 31, 2026
4 Insider transaction Apr 28, 2026 Apr 24, 2026
3 Initial insider ownership Apr 28, 2026 Apr 24, 2026
4 Insider transaction Apr 28, 2026 Apr 24, 2026
4 Insider transaction Apr 28, 2026 Apr 24, 2026
4 Insider transaction Apr 28, 2026 Apr 24, 2026
4 Insider transaction Apr 28, 2026 Apr 24, 2026
4 Insider transaction Apr 28, 2026 Apr 24, 2026
4 Insider transaction Apr 28, 2026 Apr 24, 2026
4 Insider transaction Apr 28, 2026 Apr 24, 2026
4 Insider transaction Apr 28, 2026 Apr 24, 2026
4 Insider transaction Apr 28, 2026 Apr 24, 2026
4 Insider transaction Apr 28, 2026 Apr 24, 2026
4 Insider transaction Apr 28, 2026 Apr 24, 2026
144 Notice of proposed sale Apr 27, 2026 —
4 Insider transaction Apr 27, 2026 Apr 23, 2026
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Apr 27, 2026 Apr 24, 2026
S-8 Employee stock plan registration Apr 24, 2026 —
8-K Current report
Other events
Apr 17, 2026 Apr 10, 2026
8-K Current report
Results of operations
Apr 16, 2026 Apr 16, 2026
4 Insider transaction Apr 2, 2026 Mar 31, 2026
4 Insider transaction Apr 2, 2026 Mar 31, 2026
4 Insider transaction Apr 2, 2026 Mar 31, 2026
4 Insider transaction Apr 2, 2026 Mar 31, 2026
4 Insider transaction Apr 2, 2026 Mar 31, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
4 Insider transaction Mar 25, 2026 Mar 23, 2026
3 Initial insider ownership Mar 25, 2026 Mar 23, 2026
S-8 Employee stock plan registration Mar 23, 2026 —
8-K Current report
Other events
Mar 23, 2026 Mar 23, 2026
ARS Annual report to shareholders Mar 13, 2026 Dec 31, 2025
DEFA14A Additional proxy material Mar 13, 2026 —
DEF 14A Proxy statement Mar 13, 2026 Apr 24, 2026
8-K Current report
Material agreement, New debt
Mar 9, 2026 Mar 9, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
8-K Current report
Material agreement
Feb 26, 2026 Feb 23, 2026
424B5 Prospectus supplement Feb 25, 2026 —
FWP Free writing prospectus Feb 24, 2026 —
424B3 Prospectus Feb 23, 2026 —
S-3ASR Automatic shelf registration Feb 23, 2026 —
8-K Current report
Bylaw or fiscal year change
Feb 20, 2026 Feb 20, 2026
10-K Annual report Feb 20, 2026 Dec 31, 2025
4 Insider transaction Feb 6, 2026 Feb 4, 2026
4 Insider transaction Jan 26, 2026 Jan 23, 2026
8-K Current report
Results of operations
Jan 22, 2026 Jan 22, 2026
4 Insider transaction Jan 5, 2026 Dec 31, 2025
4 Insider transaction Jan 5, 2026 Dec 31, 2025
4 Insider transaction Jan 5, 2026 Dec 31, 2025
4 Insider transaction Jan 5, 2026 Dec 31, 2025
3 Initial insider ownership Dec 23, 2025 Dec 12, 2025
3 Initial insider ownership Dec 19, 2025 Dec 12, 2025
4 Insider transaction Dec 12, 2025 Dec 11, 2025
8-K Current report
Officer or director change, Bylaw or fiscal year change
Dec 12, 2025 Dec 12, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Dec 3, 2025 —
4 Insider transaction Nov 25, 2025 Nov 25, 2025
144 Notice of proposed sale Nov 25, 2025 —
8-K Current report Nov 21, 2025 Nov 18, 2025
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Nov 20, 2025 Nov 19, 2025
10-Q Quarterly report Oct 29, 2025 Sep 30, 2025
8-K Current report
Results of operations
Oct 15, 2025 Oct 15, 2025
4 Insider transaction Oct 2, 2025 Sep 30, 2025
4 Insider transaction Oct 2, 2025 Sep 30, 2025
4 Insider transaction Oct 2, 2025 Sep 30, 2025
4 Insider transaction Oct 2, 2025 Sep 30, 2025
4 Insider transaction Sep 3, 2025 Sep 1, 2025
4 Insider transaction Sep 3, 2025 Sep 1, 2025
4 Insider transaction Aug 11, 2025 Aug 8, 2025
144 Notice of proposed sale Aug 8, 2025 —
10-Q Quarterly report Jul 30, 2025 Jun 30, 2025
8-K Current report
Results of operations
Jul 17, 2025 Jul 17, 2025
4 Insider transaction Jul 1, 2025 Jun 30, 2025
4 Insider transaction Jul 1, 2025 Jun 30, 2025
4 Insider transaction Jul 1, 2025 Jun 30, 2025
4 Insider transaction Jul 1, 2025 Jun 30, 2025
4 Insider transaction Jul 1, 2025 Jun 30, 2025
4 Insider transaction Jul 1, 2025 Jun 27, 2025
3 Initial insider ownership Jul 1, 2025 Jun 27, 2025
11-K Employee savings plan report Jun 20, 2025 Dec 31, 2024
SD Specialized disclosure (conflict minerals) May 29, 2025 —
4 Insider transaction May 2, 2025 Apr 30, 2025
8-K Current report
Officer or director change
May 1, 2025 Apr 25, 2025
144 Notice of proposed sale Apr 30, 2025 —
10-Q Quarterly report Apr 30, 2025 Mar 31, 2025
4 Insider transaction Apr 29, 2025 Apr 25, 2025
4 Insider transaction Apr 29, 2025 Apr 25, 2025
4 Insider transaction Apr 29, 2025 Apr 25, 2025
4 Insider transaction Apr 29, 2025 Apr 25, 2025
4 Insider transaction Apr 29, 2025 Apr 25, 2025
4 Insider transaction Apr 29, 2025 Apr 25, 2025
4 Insider transaction Apr 29, 2025 Apr 25, 2025
4 Insider transaction Apr 29, 2025 Apr 25, 2025
4 Insider transaction Apr 29, 2025 Apr 25, 2025
4 Insider transaction Apr 29, 2025 Apr 25, 2025
4 Insider transaction Apr 29, 2025 Apr 25, 2025
8-K Current report
Shareholder vote results
Apr 28, 2025 Apr 25, 2025
8-K Current report
Results of operations
Apr 16, 2025 Apr 16, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
ARS Annual report to shareholders Mar 14, 2025 Dec 31, 2024
DEFA14A Additional proxy material Mar 14, 2025 —
DEF 14A Proxy statement Mar 14, 2025 Apr 25, 2025
4 Insider transaction Mar 7, 2025 Mar 6, 2025
144 Notice of proposed sale Mar 7, 2025 —
144 Notice of proposed sale Mar 6, 2025 —
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Mar 3, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
144 Notice of proposed sale Mar 3, 2025 —
3 Initial insider ownership Mar 3, 2025 Mar 1, 2025
144 Notice of proposed sale Mar 3, 2025 —
144 Notice of proposed sale Mar 3, 2025 —
144 Notice of proposed sale Mar 3, 2025 —
144 Notice of proposed sale Mar 3, 2025 —
4 Insider transaction Feb 27, 2025 Feb 25, 2025
4 Insider transaction Feb 27, 2025 Feb 25, 2025
4 Insider transaction Feb 27, 2025 Feb 25, 2025
4 Insider transaction Feb 27, 2025 Feb 25, 2025
4 Insider transaction Feb 27, 2025 Feb 25, 2025
4 Insider transaction Feb 27, 2025 Feb 25, 2025
4 Insider transaction Feb 27, 2025 Feb 25, 2025
4 Insider transaction Feb 27, 2025 Feb 25, 2025
4 Insider transaction Feb 27, 2025 Feb 25, 2025
10-K Annual report Feb 21, 2025 Dec 31, 2024
4 Insider transaction Feb 7, 2025 Feb 5, 2025
144 Notice of proposed sale Feb 5, 2025 —
4 Insider transaction Jan 31, 2025 Jan 29, 2025
4 Insider transaction Jan 31, 2025 Jan 30, 2025
4 Insider transaction Jan 30, 2025 Jan 28, 2025
144 Notice of proposed sale Jan 30, 2025 —
144 Notice of proposed sale Jan 30, 2025 —
144 Notice of proposed sale Jan 29, 2025 —
8-K Current report
Results of operations
Jan 22, 2025 Jan 22, 2025
4 Insider transaction Jan 3, 2025 Dec 31, 2024
4 Insider transaction Jan 3, 2025 Dec 31, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ABT (NYSE)
Fiscal year ends
December 31
Incorporated in
IL
Headquarters
Abbott Park, IL
SEC filer status
Large accelerated filer
SEC CIK
1800

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.